Invitae Corporation (NVTA)
0.02
-0.01 (-32.20%)
At close: Feb 14, 2024, 8:59 PM
-32.20% (1D)
| Bid | n/a |
| Market Cap | 5.44M |
| Revenue (ttm) | 481.58M |
| Net Income (ttm) | -1.44B |
| EPS (ttm) | -5.36 |
| PE Ratio (ttm) | -0.0035447761194029852 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 22,459,258 |
| Avg. Volume (20D) | 12,701,614 |
| Open | 0.02 |
| Previous Close | 0.03 |
| Day's Range | 0.02 - 0.02 |
| 52-Week Range | 0.01 - 2.34 |
| Beta | 1.59 |
About NVTA
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and rare diseases; digital health solutions; and health data services. It serves patients, healthcare prov...
Industry Medical - Diagnostics & Research
Sector Healthcare
IPO Date Feb 12, 2015
Employees 1,700
Stock Exchange NYSE
Ticker Symbol NVTA
Website https://www.invitae.com